On July 8, 2026, Oursmab extended a warm welcome to Dr. Kalpesh Jain, CEO of Krishgen Biosystems, a renowned India-based enterprise specializing in life science reagents. The two sides toured our facilities and held in-depth business exchanges.

During the meeting, Oursmab presented a full overview of its product portfolio, antibody manufacturing workflow, quality control protocols and standardized warehouse management. To address the client’s core inquiries over product quality, Lab Supervisor Mr. Li and Sales Executive Mr. Jack elaborated on our rigorous quality testing procedures and R&D strengths. Professional technical questions were responded to with targeted and thorough answers, showcasing Oursmab’s solid expertise in delivering one-stop antibody solutions.

Accompanied by Oursmab’s business development and R&D teams, Dr. Kalpesh Jain toured our R&D laboratories, antibody production lines, quality control lab and finished goods warehouse. Our technical staff walked him through the complete antibody development process and our standardized quality management system.

Moving forward, Oursmab will keep deepening international partnerships in bioreagent sectors and deliver premium China-made biological products to global life science researchers worldwide.